Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Biliary Tract Diseases

Free Subscription Articles published in Gut Retrieve available abstracts of 53 articles: HTML format

Single Articles

March 2024
1. HAYLER R, Tuft C, Fisher O
   Head of pancreas mass with biliary obstruction: an unusual cause.
   Gut. 2024 Mar 22:gutjnl-2024-332268. doi: 10.1136/gutjnl-2024-332268.
   PubMed    
   
   
   
2. LARGHI A, van Wanrooij RLJ, Bronswijk M, Vanella G, et al
   Cholecystectomy following EUS-guided gallbladder drainage in patients with acute cholecystitis at high surgical risk: friend or foe?
   Gut. 2024 Mar 22:gutjnl-2024-332273. doi: 10.1136/gutjnl-2024-332273.
   PubMed    
   
   
   
3. SHI A, Liu Z, Fan Z, Li K, et al
   Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment.
   Gut. 2024 Mar 8:gutjnl-2023-331715. doi: 10.1136/gutjnl-2023-331715.
   PubMed     Abstract available
   
   
   January 2024
4. TOTH R, Brindley PJ, Vaquero J
   Enhancing the opportunities for cholangiocarcinoma precision therapy.
   Gut. 2024 Jan 16:gutjnl-2023-331480. doi: 10.1136/gutjnl-2023-331480.
   PubMed    
   
   
   December 2023
5. HANNEMANN A, Mayerle J, Beyer G
   Response to: Correspondence on 'Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion' by Wang et al.
   Gut. 2023 Dec 2:gutjnl-2023-331525. doi: 10.1136/gutjnl-2023-331525.
   PubMed    
   
   
   November 2023
6. BANG JY, Arnoletti JP, Wagner A, Varadarajulu S, et al
   EUS-guided gallbladder drainage in acute cholecystitis: long-term problems with surgical approach.
   Gut. 2023 Nov 24:gutjnl-2023-331245. doi: 10.1136/gutjnl-2023-331245.
   PubMed    
   
   
   
7. HONG JH, Yong CH, Heng HL, Chan JY, et al
   Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies.
   Gut. 2023 Nov 24:gutjnl-2023-330483. doi: 10.1136/gutjnl-2023-330483.
   PubMed     Abstract available
   
   
   
8. FRITZSCHE JA, Smit E, Ponsioen CY, Voermans RP, et al
   Time to focus on the real potential benefit of endobiliary radiofrequency ablation: stent patency in patients with cholangiocarcinoma.
   Gut. 2023 Nov 21:gutjnl-2023-331359. doi: 10.1136/gutjnl-2023-331359.
   PubMed    
   
   
   
9. CHEN L, Qiu W, Sun X, Gao M, et al
   Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis.
   Gut. 2023 Nov 9:gutjnl-2023-330784. doi: 10.1136/gutjnl-2023-330784.
   PubMed     Abstract available
   
   
   
10. NAKAGAMI S, Morita T, Yazumi S
    Rare cause of obstructive jaundice.
    Gut. 2023 Nov 6:gutjnl-2023-330496. doi: 10.1136/gutjnl-2023-330496.
    PubMed    
    
    
    October 2023
11. ARECHEDERRA M, Casadei Gardini A, Raggi C
    More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma.
    Gut. 2023 Oct 27:gutjnl-2023-331119. doi: 10.1136/gutjnl-2023-331119.
    PubMed    
    
    
    
12. WANG F, Peng L, Liu Y
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion.
    Gut. 2023 Oct 10:gutjnl-2023-331163. doi: 10.1136/gutjnl-2023-331163.
    PubMed    
    
    
    
13. LI JS, Fang J, Li ZS
    Endoluminal radiofrequency ablation prior to stenting for malignant biliary obstruction: really time to say goodbye?
    Gut. 2023 Oct 5:gutjnl-2023-331070. doi: 10.1136/gutjnl-2023-331070.
    PubMed    
    
    
    
14. ZECHER BF, Ellinghaus D, Schloer S, Niehrs A, et al
    HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.
    Gut. 2023 Oct 3:gutjnl-2023-329524. doi: 10.1136/gutjnl-2023-329524.
    PubMed     Abstract available
    
    
    September 2023
15. RUSHBROOK SM, Kendall TJ, Zen Y, Albazaz R, et al
    British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.
    Gut. 2023 Sep 28:gutjnl-2023-330029. doi: 10.1136/gutjnl-2023-330029.
    PubMed     Abstract available
    
    
    
16. O'ROURKE CJ, Salati M, Rae C, Carpino G, et al
    Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
    Gut. 2023 Sep 27:gutjnl-2023-330748. doi: 10.1136/gutjnl-2023-330748.
    PubMed     Abstract available
    
    
    August 2023
17. JAROSOVA J, Zarivnijova L, Cibulkova I, Mares J, et al
    Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
    Gut. 2023 Aug 31:gutjnl-2023-329700. doi: 10.1136/gutjnl-2023-329700.
    PubMed     Abstract available
    
    
    July 2023
18. HE X, Gao N, Lv F, Wu F, et al
    Temporal trend of mortality in patients with cirrhosis with primary biliary cholangitis and primary sclerosing cholangitis during the COVID-19 pandemic.
    Gut. 2023 Jul 24:gutjnl-2023-330271. doi: 10.1136/gutjnl-2023-330271.
    PubMed    
    
    
    April 2023
19. LEWINSKA M, Karhus ML, Ellegaard AG, Romero-Gomez M, et al
    Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
    Gut. 2023 Apr 18:gutjnl-2022-329213. doi: 10.1136/gutjnl-2022-329213.
    PubMed     Abstract available
    
    
    
20. ZORNIAK M, Sirtl S, Beyer G, Mahajan UM, et al
    Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis.
    Gut. 2023 Apr 18:gutjnl-2022-327955. doi: 10.1136/gutjnl-2022-327955.
    PubMed     Abstract available
    
    
    February 2023
21. HALLENSLEBEN ND, Stassen PMC, Schepers NJ, Besselink MG, et al
    Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study.
    Gut. 2023 Feb 27:gutjnl-2022-328258. doi: 10.1136/gutjnl-2022-328258.
    PubMed     Abstract available
    
    
    
22. BEYER G, Kasprowicz F, Hannemann A, Aghdassi A, et al
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: a population-based, cross-sectional cohort study.
    Gut. 2023 Feb 24:gutjnl-2021-326106. doi: 10.1136/gutjnl-2021-326106.
    PubMed     Abstract available
    
    
    
23. MEMON SF, Jagtap N, Reddy DN
    Reply to Sachan and Mandavdhare.
    Gut. 2023;72:408-409.
    PubMed    
    
    
    July 2022
24. MONIN MB, Baier L, Berger M, Gorny JG, et al
    SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination.
    Gut. 2022 Jul 26. pii: gutjnl-2022-328169. doi: 10.1136/gutjnl-2022-328169.
    PubMed    
    
    
    June 2022
25. MORITA S, Duda DG
    Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?
    Gut. 2022 Jun 30. pii: gutjnl-2022-327782. doi: 10.1136/gutjnl-2022-327782.
    PubMed    
    
    
    
26. FICKERT P
    Bacteria as key players in primary sclerosing cholangitis?
    Gut. 2022 Jun 28. pii: gutjnl-2022-327876. doi: 10.1136/gutjnl-2022-327876.
    PubMed    
    
    
    
27. AWONIYI M, Wang J, Ngo B, Meadows V, et al
    Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.
    Gut. 2022 Jun 15. pii: gutjnl-2021-326500. doi: 10.1136/gutjnl-2021-326500.
    PubMed     Abstract available
    
    
    
28. MAKKI K, Brolin H, Petersen N, Henricsson M, et al
    6alpha-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice.
    Gut. 2022 Jun 13. pii: gutjnl-2021-326541. doi: 10.1136/gutjnl-2021-326541.
    PubMed     Abstract available
    
    
    
29. ESSEILI MA
    Great escape: how infectious SARS-CoV-2 avoids inactivation by gastric acidity and intestinal bile.
    Gut. 2022 Jun 7. pii: gutjnl-2021-326624. doi: 10.1136/gutjnl-2021-326624.
    PubMed    
    
    
    May 2022
30. MARTIN-SERRANO MA, Kepecs B, Torres-Martin M, Bramel ER, et al
    Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
    Gut. 2022 May 18. pii: gutjnl-2021-326514. doi: 10.1136/gutjnl-2021-326514.
    PubMed     Abstract available
    
    
    
31. CAMILLERI M, Carlson P, BouSaba J, McKinzie S, et al
    Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea.
    Gut. 2022 May 17. pii: gutjnl-2022-327471. doi: 10.1136/gutjnl-2022-327471.
    PubMed     Abstract available
    
    
    
32. MACIAS RIR, Cardinale V, Kendall TJ, Avila MA, et al
    Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
    Gut. 2022 May 17. pii: gutjnl-2022-327099. doi: 10.1136/gutjnl-2022-327099.
    PubMed     Abstract available
    
    
    April 2022
33. ZHAO Y, Ren X, Lu J, He M, et al
    Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids.
    Gut. 2022 Apr 22. pii: gutjnl-2021-326617. doi: 10.1136/gutjnl-2021-326617.
    PubMed    
    
    
    
34. VOSKENS C, Stoica D, Rosenberg M, Vitali F, et al
    Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis.
    Gut. 2022 Apr 15. pii: gutjnl-2022-327075. doi: 10.1136/gutjnl-2022-327075.
    PubMed     Abstract available
    
    
    March 2022
35. SACHAN A, Mandavdhare HS
    EUS versus MRCP in patients with intermediate risk of choledocholithiasis: clinical and statistical viewpoint.
    Gut. 2022 Mar 8. pii: gutjnl-2022-327239. doi: 10.1136/gutjnl-2022-327239.
    PubMed    
    
    
    
36. PAGANO E, Elias JE, Schneditz G, Saveljeva S, et al
    Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.
    Gut. 2022;71:509-520.
    PubMed     Abstract available
    
    
    February 2022
37. JAGTAP N, Kumar JK, Chavan R, Basha J, et al
    EUS versus MRCP to perform ERCP in patients with intermediate likelihood of choledocholithiasis: a randomised controlled trial.
    Gut. 2022 Feb 10. pii: gutjnl-2021-325080. doi: 10.1136/gutjnl-2021-325080.
    PubMed     Abstract available
    
    
    January 2022
38. VARGHESE C, Nayar M, Pandanaboyana S
    SARS-CoV-2 pandemic has impacted on patterns of aetiology for acute pancreatitis and management of gallstone pancreatitis in the UK.
    Gut. 2022 Jan 17. pii: gutjnl-2021-326845. doi: 10.1136/gutjnl-2021-326845.
    PubMed    
    
    
    December 2021
39. AMPUERO J, Lucena A, Hernandez-Guerra M, Moreno-Moraleda I, et al
    Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
    Gut. 2021 Dec 7. pii: gutjnl-2021-325700. doi: 10.1136/gutjnl-2021-325700.
    PubMed    
    
    
    October 2021
40. TRAUNER M, Fuchs CD
    Novel therapeutic targets for cholestatic and fatty liver disease.
    Gut. 2021 Oct 6. pii: gutjnl-2021-324305. doi: 10.1136/gutjnl-2021-324305.
    PubMed     Abstract available
    
    
    
41. TRIVEDI PJ, Hirschfield GM
    Recent advances in clinical practice: epidemiology of autoimmune liver diseases.
    Gut. 2021;70:1989-2003.
    PubMed     Abstract available
    
    
    August 2021
42. RUFFOLO LI, Jackson KM, Kuhlers PC, Dale BS, et al
    GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
    Gut. 2021 Aug 19. pii: gutjnl-2021-324109. doi: 10.1136/gutjnl-2021-324109.
    PubMed     Abstract available
    
    
    July 2021
43. ARECHEDERRA M, Rullan M, Amat I, Oyon D, et al
    Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.
    Gut. 2021 Jul 20. pii: gutjnl-2021-325178. doi: 10.1136/gutjnl-2021-325178.
    PubMed     Abstract available
    
    
    
44. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available
    
    
    
45. YAMAO K, Kitano M, Chiba Y, Ogura T, et al
    Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.
    Gut. 2021;70:1244-1252.
    PubMed     Abstract available
    
    
    May 2021
46. LIU Q, Li B, Li Y, Wei Y, et al
    Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Gut. 2021 May 25. pii: gutjnl-2020-323565. doi: 10.1136/gutjnl-2020-323565.
    PubMed     Abstract available
    
    
    February 2021
47. FROMME M, Schneider CV, Pereira V, Hamesch K, et al
    Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
    Gut. 2021 Feb 25. pii: gutjnl-2020-323729. doi: 10.1136/gutjnl-2020-323729.
    PubMed     Abstract available
    
    
    
48. AHMED W, Joshi D, Harrison P, Reffitt D, et al
    Intraductal bile duct stents should be prioritised for removal during the pandemic.
    Gut. 2021 Feb 1. pii: gutjnl-2021-324105. doi: 10.1136/gutjnl-2021-324105.
    PubMed    
    
    
    January 2021
49. GOEPPERT B, Stichel D, Toth R, Fritzsche S, et al
    Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
    Gut. 2021 Jan 19. pii: gutjnl-2020-322983. doi: 10.1136/gutjnl-2020-322983.
    PubMed     Abstract available
    
    
    
50. AOKI S, Inoue K, Klein S, Halvorsen S, et al
    Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
    Gut. 2021 Jan 11. pii: gutjnl-2020-322493. doi: 10.1136/gutjnl-2020-322493.
    PubMed     Abstract available
    
    
    November 2020
51. WAUTERS L, Ceulemans M, Lambaerts M, Accarie A, et al
    Association between duodenal bile salts and gastric emptying in patients with functional dyspepsia.
    Gut. 2020 Nov 25. pii: gutjnl-2020-323598. doi: 10.1136/gutjnl-2020-323598.
    PubMed    
    
    
    
52. TAKEUCHI M, Vidigal PT, Guerra MT, Hundt MA, et al
    Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis.
    Gut. 2020 Nov 19. pii: gutjnl-2020-322540. doi: 10.1136/gutjnl-2020-322540.
    PubMed     Abstract available
    
    
    
53. CALDERARO J, Kather JN
    Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers.
    Gut. 2020 Nov 19. pii: gutjnl-2020-322880. doi: 10.1136/gutjnl-2020-322880.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.